Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E. Clark, Amena Usmani, Jing Cao, Ellen Araj, Fernando Torres, Ravi Sarode, Vaidehi Kaza, Chantale Lacelle, Alagarraju Muthukumar
doi: https://doi.org/10.1101/2021.04.26.21255926
Madhusudhanan Narasimhan
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Lenin Mahimainathan
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Andrew E. Clark
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Amena Usmani
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Jing Cao
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Ellen Araj
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Fernando Torres
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
Ravi Sarode
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
Vaidehi Kaza
2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
Chantale Lacelle
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas
Alagarraju Muthukumar
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas

- Supplemental Table 1 and Fig. s1[supplements/255926_file03.pdf]
Posted May 05, 2021.
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E. Clark, Amena Usmani, Jing Cao, Ellen Araj, Fernando Torres, Ravi Sarode, Vaidehi Kaza, Chantale Lacelle, Alagarraju Muthukumar
medRxiv 2021.04.26.21255926; doi: https://doi.org/10.1101/2021.04.26.21255926
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E. Clark, Amena Usmani, Jing Cao, Ellen Araj, Fernando Torres, Ravi Sarode, Vaidehi Kaza, Chantale Lacelle, Alagarraju Muthukumar
medRxiv 2021.04.26.21255926; doi: https://doi.org/10.1101/2021.04.26.21255926
Subject Area
Subject Areas
- Addiction Medicine (230)
- Allergy and Immunology (507)
- Anesthesia (111)
- Cardiovascular Medicine (1254)
- Dermatology (147)
- Emergency Medicine (283)
- Epidemiology (10043)
- Gastroenterology (500)
- Genetic and Genomic Medicine (2477)
- Geriatric Medicine (239)
- Health Economics (482)
- Health Informatics (1650)
- Health Policy (756)
- Hematology (250)
- HIV/AIDS (536)
- Medical Education (255)
- Medical Ethics (75)
- Nephrology (269)
- Neurology (2298)
- Nursing (140)
- Nutrition (354)
- Oncology (1255)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (326)
- Pediatrics (736)
- Primary Care Research (282)
- Public and Global Health (4849)
- Radiology and Imaging (844)
- Respiratory Medicine (654)
- Rheumatology (288)
- Sports Medicine (227)
- Surgery (271)
- Toxicology (44)
- Transplantation (130)
- Urology (100)